Best Private Grants for Nonprofits in Virgin Islands

The Gina M. Finzi Memorial Student Summer Fellowship Program, funded by the Lupus Foundation of America, aims to engage students in lupus research across various disciplines. Six awards of $4,000 each will be granted for projects spanning 10 weeks between May and September 2026. Eligible applicants include undergraduate and graduate/medical students, with specific allocation preferences. This initiative promotes valuable research experiences under the guidance of established faculty at accredited institutions.

The Cystic Fibrosis Foundation offers Postdoctoral Research Fellowship Awards to support research training in cystic fibrosis. The program provides up to $66,000 in salary support for the first year and $67,000 for the second year, along with $9,000 for research and travel expenses. Applicants focusing on CFTR protein function restoration or gene correction strategies are encouraged to apply. Open to U.S. citizens and residents, preference is given to recent graduates beginning their research careers.

The CAO Legislative Crisis Grant, funded by the National Education Association Staff Organization, is designed to support affiliates in creating and refining student-centered initiatives. Grants can be utilized for contract campaigns, new program development, or enhancing existing practices to improve sustainable learning conditions. This opportunity is exclusive to affiliates, ensuring a focused approach to advocacy and collective bargaining efforts that benefit students.

The Celiac Disease Foundation offers the Jocelyn Silvester Rising Villus Student Research Award to encourage medical students and residents to pursue celiac disease research. This prestigious award provides a $5,000 stipend for a 10-week mentored research experience across North America, honoring Dr. Jocelyn Silvester's contributions to the field. Recipients must secure a mentor and maintain good standing in their academic programs, ensuring a commitment to advancing celiac disease research.

The Bay Area Lyme Foundation's Emerging Leader Award supports innovative research in Lyme disease, offering two $150,000 grants to post-doctoral and early-career scientists. Applicants are encouraged to propose proof-of-concept projects that enhance diagnostics or therapeutics. The award seeks to attract talent and foster scientific leadership in biomedical sciences. Evaluation criteria include the potential for novel therapies, scientific rationale, and support from institutions. This opportunity is ideal for those new to tickborne disease research.

The Innovations for Healthy Living program invites U.S. small businesses to submit SBIR grant applications aimed at developing products or services that improve minority health and eliminate health disparities. Eligible applicants are encouraged to propose effective, affordable, and culturally acceptable solutions. Key deadlines include June 10 and December 10 in 2024, 2025, and 2026, with optional Letters of Intent due 30 days prior to submission.

The National Multiple Sclerosis Society offers the Sylvia Lawry Physician Fellowships to support MDs in acquiring essential clinical trial training. This fellowship aims to enhance expertise in conducting complex trials for MS therapies, fostering skills in protocol design, patient recruitment, and data analysis. Applicants must have relevant medical training and be engaged in ongoing MS clinical research. The program is vital for addressing the increasing demand for trained professionals in MS clinical trials, contributing to advancements in treatment.

The NIH invites eligible small business concerns to apply for STTR grants aimed at developing technologies that enhance minority health and reduce health disparities. The program encourages innovative approaches that are effective, affordable, and culturally acceptable. Key deadlines for submission include June 10, 2024, and December 10, 2024. This initiative is critical for addressing health disparities in NIH-defined populations.

The Pilot Research Grant, offered by the Society of Interventional Radiology Foundation, supports innovative research in interventional radiology to improve patient care. Grants of up to $35,000 are available for full-time faculty and post-doctorates with relevant degrees in the U.S. and Canada. Applicants must be current SIR members and can submit proposals for preliminary data generation, enhancing their chances for future funding opportunities.

The T.E.A.L. Research Grant supports innovative ovarian cancer research initiatives aligned with the mission of the Tell Every Amazing Lady About Ovarian Cancer Foundation. Designed for researchers affiliated with 501(c)3 not-for-profit institutions in the U.S., the grant aims to enhance women's health awareness and education regarding ovarian cancer. While the application period for 2025 is currently closed, interested parties should anticipate further updates in spring 2026.

The AES Infrastructure Grant, offered by the American Epilepsy Society, provides up to $50,000 to support the development of national or international multicenter research programs. This funding is intended for organizational planning sessions, infrastructure development, and pilot projects, facilitating future investments from other organizations. These grants are available annually in the spring, enabling researchers to enhance their collaborative efforts.

The National Multiple Sclerosis Society offers a Medical Student Mentorship Program that provides a four-week clinical experience for medical students who have completed at least one year of school. This program aims to raise awareness about the challenges faced by individuals with MS and generate interest in careers focused on MS care. Students gain hands-on experience under the guidance of MS specialists, enhancing their understanding of the disease and its management.

The National MS Society offers Harry Weaver Scholar Awards to support emerging researchers in multiple sclerosis. This prestigious award honors Dr. Harry Weaver's legacy and aims to facilitate independent research careers. Eligible candidates must have a doctoral degree and relevant postdoctoral training. The funding is designed to provide salary and grant support for five years, allowing awardees to establish competence in their research area. Applications should align with the Society's Pathways to Cures Roadmap.

The Morton Gould Young Composer Awards, presented by The ASCAP Foundation, support emerging composers under 30 by recognizing their original concert music. This prestigious award honors Morton Gould's legacy and offers monetary prizes to recipients. Eligible entrants must be U.S. citizens or permanent residents, aged at least 13, and can submit one original work. Previous winners of three or more awards are ineligible, ensuring a fair opportunity for new talents.

Myasthenia Gravis Rare Disease Network (MGNet)

The Myasthenia Gravis Rare Disease Network (MGNet) is a consortium of academic medical centers partnering with the Myasthenia Gravis Foundation of America and Conquer MG as well as collaborators in other research groups and industry. We are working together to enhance therapeutic development for this rare disease.

Diseases Studied

Myasthenia Gravis (MG) and its subtypes:

• Early-onset acetylcholine receptor (AChR) antibody (Ab) positive MG, which primarily affects women
• Late-onset AChR Ab positive MG with a disease bias towards men
• Paraneoplastic thymoma-associated MG
• Muscle specific kinase (MuSK) Ab positive
• AChR/MuSK antibody negative MG

Goals, Mission, & Vision

The goal of MGNet is to advance therapeutic development. To do so we have four specific aims:

• Improve the tools scientists and doctors have for performing clinical trials through rigorous monitoring of patients over time and evaluate better measures of how patients are doing.
• Identify objective measures (biomarkers) to show how the disease is responding to treatment and better predict treatment response or side effects, to improve the design of clinical trials and care of patients in clinical practice.
• Enhance the education of young investigators focusing their careers on rare diseases and specifically MG.
• Improve the awareness of scientists, physicians, and the public regarding the unique needs of patients with MG through training of clinician scientists and engagement of the patient and scientific communities in clinical research and therapeutic development.

Pilot and Feasibility Grants

Objectives

MGNet, a NIH-funded Rare Diseases Clinical Research Consortium (RDCRC) in partnership with the Myasthenia Gravis Foundation of America and Conquer MG, is seeking proposals for highly innovative investigations in early stages of development.

The priorities of the Pilot Grant Program are:

• Identification treatment responsive biomarkers
• Assess clinical measures and improve that enhance clinical trial readiness
• Evaluation of therapeutic interventions for one or more of the five distinct sub-types of MG

Pilot studies must be designed to access the resources of MGNet and focused on clinical and translational research, including fulfilling the definition of clinical and translational research and exclusion of animal studies.

Funding

The MGNet expects to fund up to two grants, each at a level of $75,000 (IDCs will be limited to 10% and included in the $75,000). Projects will be funded for 12 months. Selection among the applications received will be based on the recommendations of a review committee. A grant may be renewed for an additional one year with approval of interim report by the same review process and availability of funds. Demonstration of fulfillment of initial aims and justification for additional funding will be required. The request will be required a minimum of three months prior to the initial funding period completion.

The National MS Society's Clinician Scientist Development Awards aim to cultivate promising young investigators in multiple sclerosis research. This program supports postdoctoral fellows with three years of comprehensive training in academic medicine focused on MS. Applicants must hold a clinical degree and be licensed in the U.S. The Society prioritizes research that aligns with its Pathways to Cures Roadmap, which emphasizes stopping disease progression, restoring function, and preventing MS.

The Stephen Schwartz Musical Theatre Teacher of the Year Award, presented by The ASCAP Foundation and the Educational Theatre Association, recognizes outstanding middle and high school musical theatre teachers. Awarded annually, the recipient, selected by a panel of experts, will receive a $5,000 prize and be honored at the EdTA Theatre Education Conference in Minneapolis, MN. This prestigious award highlights the significant impact of dedicated educators in shaping the future of musical theatre.

The Aden, Jane and Roger Scholarship, offered by the Beatrice Educational Foundation, provides a $500 financial award to Beatrice High School graduating seniors actively involved in a Christian church. With a focus on financial need, applicants must maintain a minimum 3.0 GPA. Established in 1987, the Foundation supports educational opportunities within the Beatrice School District, managing a $3.8 million Endowment Fund and providing over $55,000 in scholarships annually.

The Undergraduate Winner's Circle Scholarships, offered by the Iowa Foundation for Agricultural Advancement, support Iowa youth pursuing agricultural studies at 2- or 4-year institutions. Eligible applicants must be graduates of Iowa high schools or members of 4-H or FFA chapters and maintain full-time status. This initiative aims to encourage students to excel in agricultural careers by providing financial assistance tailored to their educational needs.

Myasthenia Gravis Rare Disease Network (MGNet)

The Myasthenia Gravis Rare Disease Network (MGNet) is a consortium of academic medical centers partnering with the Myasthenia Gravis Foundation of America and Conquer MG as well as collaborators in other research groups and industry. We are working together to enhance therapeutic development for this rare disease.

Diseases Studied

Myasthenia Gravis (MG) and its subtypes:

• Early-onset acetylcholine receptor (AChR) antibody (Ab) positive MG, which primarily affects women
• Late-onset AChR Ab positive MG with a disease bias towards men
• Paraneoplastic thymoma-associated MG
• Muscle specific kinase (MuSK) Ab positive
• AChR/MuSK antibody negative MG

Goals, Mission, & Vision

The goal of MGNet is to advance therapeutic development. To do so we have four specific aims:

• Improve the tools scientists and doctors have for performing clinical trials through rigorous monitoring of patients over time and evaluate better measures of how patients are doing.
• Identify objective measures (biomarkers) to show how the disease is responding to treatment and better predict treatment response or side effects, to improve the design of clinical trials and care of patients in clinical practice.
• Enhance the education of young investigators focusing their careers on rare diseases and specifically MG.
• Improve the awareness of scientists, physicians, and the public regarding the unique needs of patients with MG through training of clinician scientists and engagement of the patient and scientific communities in clinical research and therapeutic development.

Scholar Awards

Objectives

There is a critical need for investigators prepared to conduct clinical and translational research in myasthenia gravis (MG). The MGNet Scholar Program provides individualized training and mentorship in one of two tracks, Clinical Research or Biomarker Development Research.

Award Description

The MGNet Scholar Program provides mentored research training to prepare Scholars for an independent research career in the field of MG. The MGNet Scholar Program is 1 year in duration and selected Scholars receive up to $100,000 to support salary, research costs and didactics with potential for renewal. The program will provide an additional $3,000 to travel to MGNet sites to learn specific skills and/or to scientific meeting(s) to present the results of their research. If available for renewal, the program requires approval after interim report and is contingent on demonstration of adequate progress on the research and career development plan. Indirect costs are not allowed. Scholars are encouraged to transition to NIH (e.g., K award), departmental, or private foundation support for their research and further career development.Research must constitute at least 50% of each Scholar’s professional effort. Each Scholar must form a 2-3-member advisory committee to include a primary mentor, an additional clinician investigator or collaborator, and a MGNet faculty sponsor. The advisory committee will meet with the Scholar at least quarterly to review progress and each Scholar will develop an individual academic career development plan and renew it with the committee at least every 6 months.

The Radiology Resident Research Grant, funded by The Society of Interventional Radiology Foundation, aims to promote research among residents in accredited clinical radiology training programs in the U.S. and Canada. With a budget of up to $20,000 for 12 months, this grant encourages innovative research projects that advance interventional radiology and improve patient care. Eligible applicants must designate a project advisor and secure a three-month commitment from their residency program, fostering a supportive research environment.

The Arthritis Foundation is inviting proposals for research aimed at understanding and predicting the progression of rheumatoid arthritis (RA). This includes identifying risk factors and mechanisms to prevent or slow the onset of RA. The program encourages innovative studies from early and mid-career investigators affiliated with U.S. institutions, with funding options that support both pilot and large research awards. The ultimate goal is to enhance outcomes for RA patients.

The Lawrence A. Taylor Research Fund in Petrology and Geochemistry offers financial support to two PhD students demonstrating outstanding research in Petrology and/or Geochemistry. Funded by Dong-Hwa Shin (Dawn) Taylor, this grant aims to alleviate some financial burdens associated with their doctoral studies, fostering excellence in these critical fields. Eligible candidates must be AGU student members currently enrolled in relevant doctoral programs and engaged in applicable research.

The APSF/FAER Mentored Research Training Grant aims to enhance anesthesia patient safety by funding promising anesthesiologists who are within 10 years of their first faculty appointment. This two-year grant, totaling $300,000, supports the development of independent researchers focused on perioperative safety. Recipients must allocate 60% of their time to research and career development. With this initiative, the APSF and FAER seek to cultivate the next generation of safety scientists in anesthesia.

The HIP Graduate Student Award supports first to third-year graduate students in the U.S., Canada, and Mexico aiming for a career in academic hematology. Offering a $40,000 annual stipend for two years, it funds tuition, research, and travel to the ASH annual meeting. Eligible candidates must conduct blood sciences research and demonstrate commitment to the field. This award enhances students' competitiveness for future opportunities in hematology research.

The HIP Medical Student Award by the American Society of Hematology supports underrepresented medical students in hematology research. Participants gain mentorship, a stipend up to $32,000, and valuable exposure to hematology practices. The program offers summer, flexible, and yearlong project options to accommodate students at different stages of their medical education. This initiative aims to foster diversity in the field and encourage long-term involvement in hematology.

The Investigator Initiated Research (IIR) Grants program by the Anesthesia Patient Safety Foundation aims to enhance patient safety in anesthesia care through innovative research. Grants up to $200,000 (or $300,000 with waiver) are available for projects addressing critical safety issues, with a focus on studies leading to measurable improvements in outcomes. The program encourages collaboration and creativity, prioritizing research that lacks alternative funding sources, while also supporting junior investigators with mentorship opportunities.